SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-003681 to OPGEN INC (OPGN) (CIK 0001293818) (OPGN)

OPGEN INC (OPGN) (CIK 0001293818)
Date: April 13, 2023 · CIK: 0001293818 · Accession: 0000000000-23-003681

AI Filing Summary & Sentiment

File numbers found in text: 333-271190

Date
April 13, 2023
Author
Not clearly detected
Form
UPLOAD
Company
OPGEN INC (OPGN) (CIK 0001293818)

Letter

United States securities and exchange commission logo April 13, 2023 Albert Weber Chief Financial Officer OpGen, Inc. 9717 Key West Avenue, Suite 100 Rockville, MD 20850 Re:OpGen, Inc. Registration Statement on Form S-1 Filed April 7, 2023 File No. 333-271190 Dear Albert Weber: We have limited our review of your registration statement to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Registration Statement on Form S-1 filed April 7, 2023 Cover Page 1.We note your statement that "[t]here is no arrangement for funds to be received in escrow, trust or similar arrangement." Please revise your disclosure to describe the effect on investors as a result of not having made any such arrangements. Please refer to Item 501(b)(8)(iii) of Regulation S-K. Exhibit Index, page II-4 2.We note that you intend to name a placement agent for the offering. Once known, please identify the name of the placement agent in a subsequent amendment. Additionally, it does not appear that your exhibit index currently includes a placeholder for a Placement Agent Agreement. Please update your exhibit index to include your Placement Agent

FirstName LastNameAlbert Weber Comapany NameOpGen, Inc. April 13, 2023 Page 2 FirstName LastName Albert Weber OpGen, Inc. April 13, 2023 Page 2 Agreement, or advise. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Conlon Danberg at 202-551-4466 or Celeste Murphy at 202-551-3257 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Peter Jaslow, Esq.

Show Raw Text
United States securities and exchange commission logo
April 13, 2023
Albert Weber
Chief Financial Officer
OpGen, Inc.
9717 Key West Avenue, Suite 100
Rockville, MD 20850
Re:OpGen, Inc.
Registration Statement on Form S-1
Filed April 7, 2023
File No. 333-271190
Dear Albert Weber:
            We have limited our review of your registration statement to those issues we have
addressed in our comments.  In some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Registration Statement on Form S-1 filed April 7, 2023
Cover Page
1.We note your statement that "[t]here is no arrangement for funds to be received in escrow,
trust or similar arrangement." Please revise your disclosure to describe the effect on
investors as a result of not having made any such arrangements. Please refer to Item
501(b)(8)(iii) of Regulation S-K.
Exhibit Index, page II-4
2.We note that you intend to name a placement agent for the offering. Once known, please
identify the name of the placement agent in a subsequent amendment. Additionally, it
does not appear that your exhibit index currently includes a placeholder for a Placement
Agent Agreement. Please update your exhibit index to include your Placement Agent

 FirstName LastNameAlbert Weber
 Comapany NameOpGen, Inc.
 April 13, 2023 Page 2
 FirstName LastName
Albert Weber
OpGen, Inc.
April 13, 2023
Page 2
Agreement, or advise.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration.  Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            Please contact Conlon Danberg at 202-551-4466 or Celeste Murphy at 202-551-3257
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Peter Jaslow, Esq.